Giotrif (afatinib) 40 mg film-coated tablets, 28 tablets — original (Boehringer Ingelheim, Germany) For the treatment of locally advanced or metastatic non-small cell lung cancer Targeted cancer therapy. Drug delivery from Europe +380996042415 Viber, WhatsApp
Delivery methods
- EMC post
Delivery time
- 7-10 days
Payment methods
- Payment to Revolut card
Indications
As monotherapy in patients not previously treated with tyrosine kinase inhibitors for the treatment of locally advanced or metastatic non-small cell lung cancer with EGFR mutation(s).
- Trade Name:Hyotrif
- Chemical Name:Afatinib
- Dosage:40 mg
- Quantity:28
- Form of Issue:Tablets
No reviews yet
